Quality Management System
Taking Kexing Biopharm's development strategy as the fundamental guidance and the Drug Administration Law of the People's Republic of China, China GMP, EU cGMP and other relevant laws and regulations as well as the ICH guideline Q9 on quality risk management as the basis, the Company has established a quality management system to ensure continuous and stable production of drugs that meet intended use and registration requirements while avoiding risks in safety, efficacy, quality and regulations for itself and its patients. Meanwhile, the Company has also continuously improved its quality management system according to corporate culture, quality policy and goal, as well as GMP requirements. By doing so, all quality-related activities can be carried out on the basis of "rules and regulations," which lays a solid foundation for the Company's sales and market expansion activities.